NCT04459078 2022-12-02
Clinical Study of Camrelizumab Combined With APatinib and Albumin Paclitacxel in Patients With Advanced Lung Adenocarcinoma
Hunan Cancer Hospital
Phase 2 Unknown
Clinical Trials
3 trialsNCT03376737 2017-12-18
Study of Apatinib as the Maintenance Therapy in Advanced Lung Adenocarcinoma
Henan Cancer Hospital
Phase 2 Unknown
NCT02493582 2016-02-05
The Study of Apatinib Plus CIK as the Third Line Therapy for Advanced Lung Adenocarcinoma Patients With Wild-Type EGFR
The First People's Hospital of Changzhou
Phase 2 Active not recruiting